News

Study Re-Examines ACE Inhibitor, Birth Defect Risk


 

FROM BMJ

Dr. Mitchell echoed this concern, writing that while it was reasonable to assume that untreated hypertension is less severe than treated hypertension, observational studies "have lacked data on crucial variables related to hypertension in pregnancy." He also questioned whether a "prehypertensive" condition could affect the fetus before an increase in maternal blood pressure is detected.

Dr. Li and colleagues’ study was funded by the U.S. Department of Health and Human Services and the Food and Drug Administration. Neither Dr. Li nor his colleagues declared conflicts of interest. Dr. Mitchell disclosed no conflicts of interest related to his editorial.

Pages

Recommended Reading

DES Exposure Linked to Lifetime Risk of Adverse Outcomes
MDedge Internal Medicine
Denosumab Fares Well in Extension Trials
MDedge Internal Medicine
VTE Risk Compared for Oral, Transdermal Estrogens
MDedge Internal Medicine
Some Vitamin, Mineral Supplements May Be Harmful
MDedge Internal Medicine
Many Options Exist for Treating Urinary Incontinence
MDedge Internal Medicine
Vitamin D Levels Lower in Pelvic Floor Disorders
MDedge Internal Medicine
Premenopausal Estradiol Exposure May Diminish Perimenopausal Depression
MDedge Internal Medicine
Vaginal Symptoms of Menopause Respond to Novel SERM
MDedge Internal Medicine
Hysterectomy No Boon in Early-Stage Ovarian Cancer
MDedge Internal Medicine
Frequent Hot Flashes? Check Lipid Levels
MDedge Internal Medicine